← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #720 OF 1,000 MOST-CITED

Component addition checked by 2nd person

FDA cited this observation 23 times across 23 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs23
BY FISCAL YEAR
FY20251
FY20242
FY20231
FY20221
FY20202
FY20188
FY20178

How FDA worded it — real examples

Each component is not added to a batch by one person and verified by a second person.

Innocore Sales & Marketing Inc. · Woodstock · Drugs · 2025-04-25

Each component is not added to a batch by one person and verified by a second person.

Denison Pharmaceuticals, LLC · Lincoln, Rhode Island · Drugs · 2024-07-29

Each component is not added to a batch by one person and verified by a second person.

Betone, S.A. de C.V. · Zapopan · Drugs · 2023-11-10

Each component is not added to a batch by one person and verified by a second person.

PenCef Pharma GmbH · Berlin · Drugs · 2023-09-27

Each component is not added to a batch by one person and verified by a second person.

Verde Cosmetic Labs, LLC · Northridge, California · Drugs · 2021-10-15

Each component is not added to a batch by one person and verified by a second person.

Norbrook Laboratories Limited · Newry · Drugs · 2020-02-07

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →